MedTrace Logo

Gabapentin as Adjuvant for Postoperative Pain in Pediatric Orthopedic Surgery

NCT03005483 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-12-29

No results posted yet for this study

Summary

This study is a clinical trial, prospective, randomized and double-blinded. Gabapentin oral 10 mg/kg was administered to reduce the pain intensity as well as the opioid consumption in children from 3 months to 16 years submitted unilateral limb surgery.

Conditions

  • Pain, Postoperative
  • Orthopedic Disorder

Interventions

DRUG

Gabapentin

Orthopedic Surgery was applied for the treatment of osseous disorders

OTHER

Placebo

Orthopedic Surgery was applied for the treatment of osseous disorders

Sponsors & Collaborators

  • Fortaleza University

    collaborator OTHER

  • Hospital Infantil Albert Sabin

    lead OTHER

Principal Investigators

  • Josenília Gomes, PhD · Fortaleza University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
3 Months
Max Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-01-31
Completion
2016-05-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03005483 on ClinicalTrials.gov